NCT04207216

Brief Summary

Psoriasis Vulgaris is a chronic, recurrent, inflammatory and hyperproliferative skin disease. Joint involvement is common along with skin involvement. However, metabolic diseases, such as cardiovascular diseases can be accompanied by many systemic diseases, chronic and repetitive due to the quality of life and psychological status of patients can affect. Today, although the treatment is repetitive, chronic and requires follow-up due to the disease patients can turn to alternative and complementary medicine techniques. In recent years, studies on alternative medicine and complementary therapies have been noted in the medical literature. These studies also include Case Reports related to psoriasis vulgaris. However, in our country, there is no study that tells us whether patients with psoriasis vulgaris apply these treatments or not and what the practitioners think about the success of the treatment. The aim of the study will be to clarify issues such as whether patients with Psoriasis Vulgaris apply alternative medicine and complementary therapies for their disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,618

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 3, 2019

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 20, 2019

Completed
12 days until next milestone

Study Start

First participant enrolled

January 1, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2020

Completed
Last Updated

January 11, 2021

Status Verified

January 1, 2021

Enrollment Period

6 months

First QC Date

December 3, 2019

Last Update Submit

January 8, 2021

Conditions

Psoriasis Vulgaris

Outcome Measures

Primary Outcomes (1)

  • Alternative medicine and complementary therapies that psoriasis vulgaris patients apply without informing the doctor, how they learn these techniques, what make them use these techniques for their illness

    July 2020

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

psoriasis vulgaris patients

You may qualify if:

  • psoriasis vulgaris patients

You may not qualify if:

  • the patients that don't want to answer the questions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Melek Aslan Kayıran

Istanbul, Turkey (Türkiye)

Location

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Spesialist Dermatologist Doctor

Study Record Dates

First Submitted

December 3, 2019

First Posted

December 20, 2019

Study Start

January 1, 2020

Primary Completion

July 1, 2020

Study Completion

July 1, 2020

Last Updated

January 11, 2021

Record last verified: 2021-01

Locations

TU(1)